Clinical Trial of Approaches to Prostate Cancer Surgery
Clinical TrIAL of Approaches to Prostate cAncer suRgery
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 40 Years to 80 Years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Investigators will compare cancer control and health-related quality of life outcomes through patient questionnaires and medical record review."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study compares two ways to remove the prostate: one that saves a layer of tissue around it and standard surgery. It is for men with prostate cancer that has not spread beyond the prostate, and it compares cancer control and effects on daily life, including sexual and bladder function.
This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Male.
- The age rule says “40 or older or 80 or younger.” Ask the study team to confirm what this means.
- Scheduled for surgery to remove the prostate for cancer that has not spread beyond it.
- Able to read and speak English or Spanish.
- Willing to sign a form agreeing to join and follow the study rules.
Who can't join
- Past major surgery or radiation treatment in the pelvis, the lower belly area.
- Possible cancer spread to nearby lymph nodes, small structures that help fight infection. The study defines this as any lymph node larger than 1 centimeter across.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Male sex * Age ≥40 years or ≤80 years * Scheduled for radical prostatectomy for clinically localized prostate cancer * Able to read and speak English or Spanish * Willingness to sign informed consent and adhere to the study protocol Exclusion Criteria: * Prior major pelvic surgery or radiotherapy * Suspicion of N1 disease (i.e., any lymph node greater than 1cm in maximal diameter)
Study sites (9)
CA
- Beckman Research Institute of City of Hope · Duarte, CA 91010Radhika Nagalla, PharmD · Study contact · 847-502-0334 · rnagalla@coh.orgClayton Lau, MD · Principal investigatorMore trials in Duarte
DC
- Georgetown University · Washington D.C., DC 20007Keith Kowalczyk, MD · Study contact · Keith.Kowalczyk@medstar.netKeith Kowalczyk, MD · Principal investigatorMore trials in Washington D.C.
IL
- Northwestern University · Chicago, IL 60611Mary Kate Keeter, MPH · Study contact · 312-694-6082 · mary.fitzgerald@northwestern.eduEdward M Schaeffer, MD PhD · Principal investigatorMore trials in Chicago
MA
- Beth Israel Deaconess Medical Center (BIDMC) · Boston, MA 02215Gabriela Nieto Blanco, MS · Study contact · 617-632-1047 · gnietobl@bidmc.harvard.eduSarah Duncan, BA · Study contact · sduncan1@bidmc.harvard.eduPeter Chang, MD, MPH · Principal investigatorMore trials in Boston
MD
- Johns Hopkins University · Baltimore, MD 21287Rana Harb, MS · Study contact · 410-502-5500 · rharb1@jhmi.eduMohamad E Allaf, MD · Principal investigatorMore trials in Baltimore
NJ
- Hackensack Meridian Health · Hackensack, NJ 07601Samanta Baboolall-Aracena · Study contact · 551-996-3960 · samanta.baboolallaracena@hmhn.orgNitin Yerram, MD · Principal investigatorMore trials in Hackensack
NY
- NewYork-Presbyterian Queens · Flushing, NY 11355Neal Patel, MD · Study contact · 718-303-3720 · nap9055@med.cornell.eduNeal Patel, MD · Principal investigatorMore trials in Flushing
- Memorial Sloan Kettering Cancer Center · New York, NY 10065Melissa McCarter · Study contact · mccartem@mskcc.orgBehfar Ehdaie, MD · Principal investigatorMore trials in New York
- Weill Cornell Medicine · New York, NY 10065Jim C Hu, MD MPH · Study contact · 646-962-9600 · jch9011@med.cornell.eduMore trials in New York